Carevive OPT-IN® - Logo

Unlocking the Missing Puzzle Piece in Cancer Real-World Data

Carevive OPT-IN™ - Unlocking the Missing Puzzle Piece in Cancer Real-World Data

Collecting Patient Experience Data

Value Proposition for Life Science Companies

Provide commercial insights

  • Characterize burden of illness, patient functional status, symptom impact on real-world time-on-treatment (rwToT)
  • Evaluate comparative Patient Experience across evidence-based options
  • Identify sub-populations benefiting from treatment

Inform new drug development and new indications

  • Understand patient adherence and patient populations
  • Provide Patient Experience Data for new drug applications
  • Create synthetic control arms
  • Use regulatory grade data to support FDA submissions for label expansion

Support Market Access

  • Identify hospitalization & discontinuation trends by treatment
  • Understand comparative overall cost of care across evidence-based options
  • Collaborate with payors/providers on care management strategies to improve value

Building the Largest Real-World Cancer Patient Experience Database

Carevive OPT-IN® – The Oncology Pragmatic Trial Investigator Network

Funded by a growing list of life science companies, Carevive OPT-IN® is a novel and unique real-world patient experience dataset consisting of EHR-derived clinical data and longitudinal patient-reported outcomes (PRO). Together, this combination presents the most comprehensive picture of real-world symptoms of disease and treatment in cancer.

Life science companies can license these data to:

  • Support drug development, commercial, and market access efforts with novel evidence and insights including how and when therapies are being used in the real-world setting, differences between trial results and real-world data and longitudinal patient experience
  • Conduct bespoke research in collaboration with Carevive OPT-IN® sites and their patients
  • Become Carevive design-partners in other cancer types

Tumor registries to be initiated in 2020-2022

Myeloma

LIVE

Chronic Lymphocytic Leukemia
Renal Cell Carcinoma
Breast Cancer

LIVE

DLBCL
Follicular Lymphoma
Urothelial
Lung Cancer

LIVE

Ovarian Cancer

LIVE

Hepatocellular Carcinoma
Prostate Cancer
AML

LIVE

Stomach Cancer
Colorectal Carcinoma
Pancreatic Cancer
Head and Neck
0
Total US 2019 Analytic Cases
0
Carevive OPT-IN® Network Analytic Cases
0
%
Share of Total Cancer Market

OPT-imizing Patient Experience Data

REQUEST A MEETING TO LEARN MORE
Carevive OPT-IN™ - Cancer Real-World Data